MediPharm Labs Completes Payment of All Convertible Debt
05. Januar 2022 07:00 ET
|
MediPharm Labs Corp.
TORONTO, Jan. 05, 2022 (GLOBE NEWSWIRE) -- MediPharm Labs Corp. (TSXV: LABS) (OTCQX: MEDIF) (FSE: MLZ) (“MediPharm Labs” or the “Company”) a pharmaceutical company specialized in precision-based...
MediPharm Labs Receives Award for CBD Brand of the Year
22. Dezember 2021 07:00 ET
|
MediPharm Labs Corp.
MediPharm Labs pharma-quality CBD dominant oil line has been awarded CBD Brand of the year by KIND Magazine.MediPharm Labs’ CBD products have seen steady revenue growth and notoriety in 2021,...
MediPharm Labs Provides Operational Update and Confirms Profitability Improvement Initiatives are Underway
21. Dezember 2021 07:00 ET
|
MediPharm Labs Corp.
Strong cash balance and continued reduction of convertible debt to less than $500K.Opportunities for optimization of the operating strategy between Australia and Canada as the Canadian Drug...
MediPharm Labs Announces Changes to Board of Directors
07. Dezember 2021 07:00 ET
|
MediPharm Labs Corp.
BARRIE, Ontario, Dec. 07, 2021 (GLOBE NEWSWIRE) -- MediPharm Labs Corp. (TSX: LABS) (OTCQX: MEDIF) (FSE: MLZ) (“MediPharm Labs” or the “Company”) a pharmaceutical company specialized in...
MediPharm Labs Completes Medical Cannabis Export to Barbados
26. November 2021 07:00 ET
|
MediPharm Labs Corp.
Patient based delivery of medical cannabis executed with approval from both Barbados and Canadian Health Authorities.This marks the fourth new country entered by MediPharm Labs in 2021, following...
MediPharm Labs Expands CBN Portfolio with Two New Products
23. November 2021 07:15 ET
|
MediPharm Labs Corp.
A leader in CBN products, MediPharm Labs, adds CBN:CBD products to its wellness portfolio for consumers and patients looking for a product without THC effects.New CBN products include CBN:CBD 1:2...
MediPharm Reports Third Quarter 2021 Results; Announces New CEO to Start Today
15. November 2021 07:15 ET
|
MediPharm Labs Corp.
BARRIE, Ontario, Nov. 15, 2021 (GLOBE NEWSWIRE) -- MediPharm Labs Corp. (TSX: LABS) (OTCQX: MEDIF) (FSE: MLZ) (“MediPharm” or the “Company”) a pharmaceutical company specialized in precision-based...
MediPharm Labs Sets Date to Report Third Quarter 2021 Financial Results
10. November 2021 07:00 ET
|
MediPharm Labs Corp.
TORONTO, Nov. 10, 2021 (GLOBE NEWSWIRE) -- MediPharm Labs Corp. (TSX: LABS) (OTCQX: MEDIF) (FSE:MLZ) (“MediPharm Labs” or the “Company”) a pharmaceutical company specialized in precision-based...
MediPharm Labs Appoints New Chief Executive Officer
21. Oktober 2021 07:00 ET
|
MediPharm Labs Corp.
C-Suite healthcare leader, Bryan Howcroft, to lead MediPharm’s next phase of international growth as CEO. Bryan will apply his experience in registering, distributing, and selling medically...
MediPharm Labs Completes a New Cannabis Oil Delivery to German Partner Vayamed
19. Oktober 2021 07:00 ET
|
MediPharm Labs Corp.
New strategic partnership through the delivery of GMP extract to Germany for Vayamed, the medical cannabis business unit of Sanity GroupVayamed is a well-established operating medical cannabis company...